Given both Ighg2b/Ighm and Ighg3/Ighm showed significant negative correlations with talus bone volume, we performed a multiple linear regression to control for the effects of the differentially expressed immunoglobulins and the stage of arthritis (Early vs Advanced). This evidence concerns the gene IGHG3 and arthritic joint disease.